A groundbreaking technology could soon allow opticians to detect early signs of dementia during routine eye exams. Using artificial intelligence (AI) to analyze retinal blood vessels, this method offers a fast, non-invasive way to assess brain health and identify potential neurodegenerative diseases like Alzheimer’s.
AI Technology Scans the Eye for Early Signs of Cognitive Decline
The AI system, called Quartz, works by examining retinal images in seconds. It measures the size, shape, and twisting of tiny blood vessels. These vessels are closely connected to those in the brain, and changes in their structure may signal early cognitive decline.
Researchers at City St George’s University of London conducted a study analyzing the eye scans of more than 63,000 people aged between 40 and 69 using Quartz. Participants also underwent cognitive tests assessing memory, reaction time, and intelligence. The study found that individuals with narrower or more irregularly shaped retinal blood vessels tended to perform worse on these cognitive tests, suggesting a potential link between retinal health and brain function.
Early Detection Could Lead to Better Treatment Options
Scientists believe that changes in the retinal blood vessels could indicate reduced blood flow to the brain, which may be an early warning sign of dementia or Alzheimer’s disease. Early detection of these changes could help identify at-risk individuals and facilitate earlier intervention, leading to better outcomes.
Professor Chris Owen, the lead author of the study, believes this technology could be integrated into routine optician visits in the near future. A simple eye scan could provide an efficient, cost-effective way to assess dementia risk without the need for invasive tests.
David Thomas from Alzheimer’s Research UK views the AI-powered eye scan technology as a “gamechanger.” He stresses that combining this new approach with existing diagnostic tools, such as brain scans, could lead to more accurate diagnoses and faster support for patients. Early detection could allow for better management of symptoms, improving the quality of life for those affected by dementia.
A Future Breakthrough in Dementia Diagnosis
Although the technology is still in the development phase and not yet widely available, experts believe that AI-powered eye scans could soon be a common tool in high-street opticians. As new treatments for dementia continue to emerge, early detection through AI eye scans could play a pivotal role in improving patient outcomes.
Currently, many neurodegenerative conditions, such as Alzheimer’s, are diagnosed only in advanced stages when treatment options are more limited. By incorporating AI into routine eye exams, doctors could identify signs of dementia before significant cognitive damage occurs, allowing for earlier treatment and intervention.
This approach could be particularly useful in identifying at-risk individuals long before symptoms appear, which could lead to better long-term management of the condition.
A New Era in Dementia Detection
With advancements in AI and retinal imaging technology, the potential for revolutionizing dementia care is vast. Researchers are optimistic that, as the technology continues to develop, AI-powered eye scans will become an essential tool for early detection and intervention.
This breakthrough could offer a faster, less expensive alternative to current diagnostic methods, offering hope for millions of people who are at risk of developing dementia. As AI systems like Quartz evolve and become more accessible, they could pave the way for a new era in brain health management.
AI-powered eye scans could soon provide a simple and non-invasive way to assess dementia risk, helping doctors diagnose neurodegenerative conditions early, leading to better outcomes for patients worldwide.
For more information on developments in AI and health, visit EuroNews24.